Literature DB >> 10218224

The outcome of the first 165 orthotopic liver transplants in Scotland.

A J Bathgate1, O J Garden, J R Forsythe, K K Madhaven, N D Finlayson, K J Simpson, P C Hayes, A J MacGilchrist.   

Abstract

The Scottish Liver Transplant Unit is now in its sixth year of existence. We present the outcome of the first 165 transplants which have at least 12 months follow up. The overall patient (n = 143) survival rates at 1, 3 and 5 years were 86.6%, 79.3% and 74.7% and the graft survival rates were 76.9%, 69.1% and 64.8%. The one year survival rate for patients with chronic liver disease (n = 113) was 89.2% compared with 76.6% for acute liver failure (Breslow = 0.05). The one year survival rate for the first 71 patients receiving their primary graft was 81.7% compared with 91.5% for the subsequent 71 patients (Breslow = 0.09). The majority of deaths (n = 29) were due to sepsis (n = 7), at operation (n = 6) or due to graft vascular insufficiency (n = 4). There were two cases of de novo haematological malignancy. The outcome of the first 165 transplants in Scotland compares very well with other countries throughout the world.

Entities:  

Mesh:

Year:  1999        PMID: 10218224     DOI: 10.1177/003693309904400104

Source DB:  PubMed          Journal:  Scott Med J        ISSN: 0036-9330            Impact factor:   0.729


  5 in total

1.  Analysis of prognosis on patients with severe viral hepatitis using the model for end-stage liver disease.

Authors:  Zhi-Hong Weng; Shu-Qing Cai
Journal:  World J Gastroenterol       Date:  2005-02-14       Impact factor: 5.742

2.  Increasing survival of hepatocellular carcinoma patients in Scotland: a review of national cancer registry data.

Authors:  John K Dunbar; John Dillon; O James Garden; David H Brewster
Journal:  HPB (Oxford)       Date:  2012-10-15       Impact factor: 3.647

Review 3.  Neuropsychological aspects of liver disease and its treatment.

Authors:  R E O'Carroll
Journal:  Neurochem Res       Date:  2007-10-24       Impact factor: 3.996

4.  Alteration in cellular immunity after chronic hepatitis B deteriorated into severe hepatitis and its significance.

Authors:  Gu Xibing; Yang Xiaojuan; Lu Zhonghua; Wang Juanhua
Journal:  Hepat Mon       Date:  2011-10       Impact factor: 0.660

5.  Analysis of T Cell Receptor Vβ Diversity in Peripheral CD4+ and CD8+ T Lymphocytes Obtained From Patients With Chronic Severe Hepatitis B.

Authors:  Ying Xiong; Yan Tan; Yu Guo Song
Journal:  Hepat Mon       Date:  2014-02-25       Impact factor: 0.660

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.